[18.5.1525.1]
via crossref
|
Does ADMA Cause Endothelial Dysfunction?
J. P. Cooke
2000
Arteriosclerosis, Thrombosis and Vascular Biology
doi:10.1161/01.atv.20.9.2032
pmid:10978245
|
web.archive.org
[PDF]
|
[b1]
via fuzzy
|
Asymmetric Dimethylarginine (ADMA) and Cardiovascular Disease
Seiji Ueda,
Sho-ichi Yamagishi,
Utako Kaneyuki,
Seiya Okuda
2008
Vascular Disease Prevention
doi:10.2174/1567270000603010041
|
|
[18.5.1525.3]
via crossref
|
Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental Hypertension
H. Matsuoka,
S. Itoh,
M. Kimoto,
K. Kohno,
O. Tamai,
Y. Wada,
H. Yasukawa,
G. Iwami
(+ more)
1997
Hypertension
doi:10.1161/01.hyp.29.1.242
pmid:9039109
|
web.archive.org
[PDF]
|
[18.5.1525.4]
via crossref
|
Endogenous Nitric Oxide Synthase Inhibitor
Hiroshi Miyazaki,
Hidehiro Matsuoka,
John P. Cooke,
Michiaki Usui,
Seiji Ueda,
Seiya Okuda,
Tsutomu Imaizumi
1999
Circulation
doi:10.1161/01.cir.99.9.1141
pmid:10069780
|
web.archive.org
[PDF]
|
[18.5.1525.5]
via crossref
|
Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes
L. Tarnow,
P. Hovind,
T. Teerlink,
C. D.A. Stehouwer,
H.-H. Parving
2004
Diabetes Care
doi:10.2337/diacare.27.3.765
pmid:14988299
|
web.archive.org
[PDF]
|
[18.5.1525.6]
via crossref
|
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
A. Leone,
S. Moncada,
P. Vallance,
A. Calver,
J. Collier
1992
The Lancet
doi:10.1016/0140-6736(92)90865-z
pmid:1347093
|
|
[18.5.1525.7]
via crossref
|
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
Carmine Zoccali,
Stefanie M Bode-Böger,
Francesca Mallamaci,
Frank Antonio Benedetto,
Giovanni Tripepi,
Lorenzo Salvatore Malatino,
Alessandro Cataliotti,
Ignazio Bellanuova
(+ more)
2001
The Lancet
doi:10.1016/s0140-6736(01)07217-8
pmid:11784625
|
web.archive.org
[PDF]
|
[18.5.1525.8]
via crossref
|
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Veli-Pekka Valkonen,
Hannu Päivä,
Jukka T Salonen,
Timo A Lakka,
Terho Lehtimäki,
Juha Laakso,
Reijo Laaksonen
2001
The Lancet
doi:10.1016/s0140-6736(01)07184-7
pmid:11784629
|
|
[18.5.1525.9]
via crossref
|
Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease: Results from the AtheroGene Study
R. Schnabel
2005
Circulation Research
doi:10.1161/01.res.0000181286.44222.61
pmid:16100045
|
web.archive.org
[PDF]
|
[18.5.1525.10]
via crossref
|
Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease
K. Matsuguma
2006
Journal of the American Society of Nephrology
doi:10.1681/asn.2005121379
pmid:16807406
|
web.archive.org
[PDF]
|
[18.5.1525.11]
via crossref
|
Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease Study
D. Fliser
2005
Journal of the American Society of Nephrology
doi:10.1681/asn.2005020179
pmid:15930091
|
web.archive.org
[PDF]
|
[18.5.1525.12]
via crossref
|
Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease: A Competing Risks Modeling Approach
P. Ravani
2005
Journal of the American Society of Nephrology
doi:10.1681/asn.2005010076
pmid:15944335
|
web.archive.org
[PDF]
|
[18.5.1525.13]
via crossref
|
Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
Carmine Zoccali,
Jan T Kielstein
2006
Current opinion in nephrology and hypertension
doi:10.1097/01.mnh.0000222701.22583.e8
pmid:16609301
|
|
[18.5.1525.14]
via crossref
|
Nitric Oxide Modulates Vascular Disease in the Remnant Kidney Model
Duk-Hee Kang,
Takahiko Nakagawa,
Lili Feng,
Richard J. Johnson
2002
American Journal of Pathology
doi:10.1016/s0002-9440(10)64175-2
pmcid:PMC1850677
pmid:12107108
|
web.archive.org
[PDF]
|
[18.5.1525.15]
via crossref
|
Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase
A. Erdely
2003
Journal of the American Society of Nephrology
doi:10.1097/01.asn.0000086476.48686.7d
pmcid:PMC2747486
pmid:14514730
|
web.archive.org
[PDF]
|
[18.5.1525.16]
via crossref
|
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
T Murohara,
T Asahara,
M Silver,
C Bauters,
H Masuda,
C Kalka,
M Kearney,
D Chen
(+ more)
1998
Journal of Clinical Investigation
doi:10.1172/jci1560
pmcid:PMC508846
pmid:9616228
|
web.archive.org
[PDF]
|
[18.5.1525.17]
via crossref
|
Regulation of Cytokine-Induced Nitric Oxide Synthesis by Asymmetric Dimethylarginine: Role of Dimethylarginine Dimethylaminohydrolase
S. Ueda
2002
Circulation Research
doi:10.1161/01.res.0000052990.68216.ef
pmid:12574151
|
web.archive.org
[PDF]
|
[18.5.1525.18]
via crossref
|
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF
Sho-ichi Yamagishi,
Kazuo Nakamura,
Seiji Ueda,
Seiya Kato,
Tsutomu Imaizumi
2005
Cell and Tissue Research
doi:10.1007/s00441-005-1094-8
pmid:15846509
|
|
[18.5.1525.19]
via crossref
|
Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease
R. H. Boger,
S. M. Bode-Boger,
W. Thiele,
W. Junker,
K. Alexander,
J. C. Frolich
1997
Circulation
doi:10.1161/01.cir.95.8.2068
pmid:9133517
|
web.archive.org
[PDF]
|
[18.5.1525.20]
via crossref
|
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis
Jan T. Kielstein,
Shelley R. Salpeter,
Stefanie M. Bode-Boeger,
John P. Cooke,
Danilo Fliser
2006
Nephrology, Dialysis and Transplantation
doi:10.1093/ndt/gfl292
pmid:16766542
|
|
[18.5.1525.21]
via crossref
|
Symmetrical Dimethylarginine: A New Combined Parameter for Renal Function and Extent of Coronary Artery Disease
S. M. Bode-Boger
2006
Journal of the American Society of Nephrology
doi:10.1681/asn.2005101119
pmid:16481412
|
web.archive.org
[PDF]
|
[18.5.1525.22]
via crossref
|
Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats
Katari A. Carello,
Steven E. Whitesall,
Mary C. Lloyd,
Scott S. Billecke,
Louis G. D'Alecy
2006
American Journal of Physiology. Heart and Circulatory Physiology
doi:10.1152/ajpheart.00208.2005
pmid:16113067
|
web.archive.org
[PDF]
|
[b22]
via grobid
|
Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448 -1457, 2001
|
|
[18.5.1525.24]
via crossref
|
Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases
J.-J. Boffa
2003
Journal of the American Society of Nephrology
doi:10.1097/01.asn.0000060574.38107.3b
pmid:12707384
|
web.archive.org
[PDF]
|
[18.5.1525.25]
via crossref
|
TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy
Kiyoshi Tamaki,
Seiya Okuda,
Takashi Ando,
Taketo Iwamoto,
Masaru Nakayama,
Masatoshi Fujishima
1994
Kidney International
doi:10.1038/ki.1994.68
pmid:8164441
|
web.archive.org
[PDF]
|
[18.5.1525.26]
via crossref
|
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
S Okuda,
L R Languino,
E Ruoslahti,
W A Border
1990
Journal of Clinical Investigation
doi:10.1172/jci114731
pmcid:PMC296747
pmid:2200803
|
web.archive.org
[PDF]
|
[18.5.1525.27]
via crossref
|
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease
K. Caglar,
M.I. Yilmaz,
A. Sonmez,
E. Cakir,
A. Kaya,
C. Acikel,
T. Eyileten,
M. Yenicesu
(+ more)
2006
Kidney International
doi:10.1038/sj.ki.5001632
pmid:16820789
|
web.archive.org
[PDF]
|
[18.5.1525.28]
via crossref
|
Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease
Jan T. Kielstein,
Rainer H. Böger,
Stefanie M. Bode-Böger,
Jürgen C. Frölich,
Hermann Haller,
Eberhard Ritz,
Danilo Fliser
2002
Journal of the American Society of Nephrology
doi:10.1681/asn.v131170
|
web.archive.org
[PDF]
|
[b28]
via grobid
|
Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Boger R; CREED Investigators: Asymmetric dimethylarginine, c-reactive protein, and carotid intima- media thickness in end-stage renal disease. J Am Soc Neph- rol 13: 490 -496, 2002
|
|
[18.5.1525.30]
via crossref
|
Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B
Ellen I. Closs,
Fatima Z. Basha,
Alice Habermeier,
Ulrich Förstermann
1997
Nitric oxide
doi:10.1006/niox.1996.0106
pmid:9701046
|
|